Eastman Chemical (EMN) Stock Forecast & Price Target
$7.73B
Market Cap
17.23
P/E
10.71
Forward P/E
49
Score
EMN price $67.58 +0.91 +1.36%
Stocklytics score rationale: value 74, quality 32, growth 40.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 8945000000 | 9514000000 | 10122000000 | 9247000000 | 8464000000 | 10483000000 | 10535000000 | 9198000000 | 9382000000 | 8752000000 |
Eastman Chemical Company functions as a worldwide provider of specialized materials. Its Additives & Functional Products division offers a comprehensive range, including hydrocarbon and rosin resins, organic acid-based solutions, and amine-derived building blocks. This segment also provides agricultural chemicals like metam-based soil fumigants, thiram and ziram fungicides, and plant growth regulators. Additional…
Consensus Buy from 18 analysts. Average price target $76.89, +13.8% versus the current price. Low $68.00. High $85.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $76.89 for Eastman Chemical (EMN), 13.8% above the current price of $67.58. Of 18 analysts covering the stock, 9 rate it Buy or Strong Buy, 9 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $68.00 |
|---|---|
| Average | $76.89 |
| High | $85.00 |
The average is 13.8% above the current price of $67.58.
Of 18 analysts, 9 rate Eastman Chemical Buy or Strong Buy, 9 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $6.31, revenue $9.27 billion. 2027, EPS $6.65, revenue $9.44 billion.
The Stocklytics Score for EMN is 49 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$76.89 average, with a published range of $68.00 to $85.00.
The consensus is Buy from 18 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $6.31. The average revenue estimate is $9.27 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Eastman Chemical · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$7.73B
Market Cap
17.23
P/E
10.71
Forward P/E
49
Score